Articles On Telix Pharmaceuticals (ASX:TLX)

Highlights ASX 200 closed lower influenced by geopolitical tensions and US market trading calendar Silver price surge and easing trade friction supported gains in mining and energy sectors Key resource stocks including WAF,...

Medical device makers – including ASX-listed heart plays – are the likely winners from the US healthcare chaos Painchek hopes for US device approval by September Mayne Pharma flags legal action over Cosette bid but also waves an olive bra...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and KYOTO, Japan, June 4, 2025 /PRNewswire/ – Telix Pharmac...

AI is reshaping microbiology in the labs Big Pharma taps Clever Culture’s APAS system Here are ASX biotechs with global health deals    Step into a modern microbiology lab today and you might notice something’s different. The culture plat...

Highlights ASX 200 posts slight gain in a subdued and low-volume session Energy sector gains on project approval, pharmaceuticals lift on US trade ruling Stocks with US and China exposure see limited movement despite tariff...

With some common types of cancers including breast and lung, therapies have developed at a rapid clip. The same can’t be said for pancreatic cancer, which is not among the most common tumours but ranks number one as the deadliest. Only 12%...

When it comes to managing your self-managed super fund (SMSF), the goal is clear: grow your wealth, protect your capital, and generate reliable returns over the long term. That's why choosing the right ASX shares for your SMSF is so importa...

Highlights Diverse performance across ASX 200 technology sector reflected by major players such as Catapult Group International (CAT), Nuix Limited (NXL) and Telix Pharmaceuticals (TLX) Catapult’s Vector 8 release, Nuix’s researc...

Highlights: SKS Technologies advances after securing a major data centre contract Graphite and gold stocks post broad gains amid global commodity developments Earlypay block trade and Perenti contract announcement stir secto...

AFT Pharmaceuticals boosts revenue, but profits still lag Telix Pharmaceuticals chair and CEO reflect on a prosperous 2024 – and promise more riches to come Dimerix’s pivotal trail passes another safety check   The bourse’s ‘forgotten’ dr...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, May 20, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

Starting your investing journey can feel overwhelming — but it doesn't have to be. You don't need thousands of dollars or a background in finance to begin building wealth. In fact, with just $500, you can get started on the ASX with expos...

Highlights Core Lithium’s stock experiences strongest daily movement since a previous multi-year high Finniss Project study outlines lowered operational and capital costs with increased production ASX 200 continues upward tr...

US President Donald Trump has signed an executive order aimed at reducing drug costs for Americans, by up to 80% immediately. The move immediately hit Australia's pharmaceutical industry as 3 ASX pharmaceutical stocks crashed up to 10% s...

Compumedics’ MEG unit can scan adult and kid’s heads at the same time – a technically tricky task Microba’s comprehensive gut testing reveals all is not well in the tummy region Trump’s drug pricing blitz should be “immaterial”, says Telix...

We're now in the middle of May, and after a rocky start to the quarter, the ASX has rebounded strongly in recent weeks. While some investors may be wondering if they've missed the moment, smart investors know this simple truth: it's never t...

 Investors with a short position in wound care house Polynovo face a nervous wait Oz drug stocks partly recover after swooning yesterday on Trump drug-pricing edict Wellnex Life rediscovers its sales mojo, while Elinixol Wellness goes to t...

Highlights  ASX200 climbs amid global trade relief  Technology stocks lead, WiseTech surges  Gold miners slide as investors shift to equities  The Australian sharemarket made a strong upward move on renewed global optimism after t...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, May 13, 2025 /PRNewswire/ — Telix Pharmac...

Highlights Mineral Resources (MIN) observed increased market activity amid global trade updates. Elixir Energy (EXR) advanced following a new strategic direction led by recent leadership changes. Biotechnology stocks, includ...

Some of the ASX’s best-known pharmaceutical companies – including Neuren, Telix and Clarity – have reported losses on Monday, after Donald Trump announced a plan to cut prescriptions drug prices by up to 80% via an executive order. The i...

Highlights ASX pharmaceutical stocks saw notable declines following U.S. policy comments. Trump's proposal aims to drastically cut U.S. prescription drug prices. Companies with U.S.-based pipelines or approvals felt the immediate mark...

Smart investors know that long-term wealth isn't built on hype — it is built by owning quality businesses with real earnings power, global opportunity, and the ability to compound growth over time. Right now, a handful of ASX 200 shares a...

A 10-bagger describes an investment that has increased 10 times in value.  The term '10-bagger' was first coined by Fund Manager Peter Lynch in his book One Up On Wall Street. Landing one of these is every investor's dream.  Which s...

Neuren says the number of patients discontinuing its Rett syndrome drug has fallen by two-thirds over the last year LTR Pharma launches a secondary program for swallowing disorders Telix targets throat – and other – cancers Neuren Pharmac...

Highlights Energy and mining sectors drive ASX gains CSL drags healthcare lower US-China trade talks boost investor sentiment Australia's sharemarket reversed a two-day slide on Wednesday, supported by rising energy and mining sto...

The big-name biotechs present short-term trading opportunities for bold investors Nothing to see here, says Sigma Healthcare Broker reckons Mach 7 shares should be worth four times more than their current value   The topsy-turvy market ha...

Highlights: Goodman Group (ASX:GMG) focuses on global industrial property and digital infrastructure. Telix Pharmaceuticals (ASX:TLX) develops radiopharmaceuticals for medical imaging and therapy. Both companies are highligh...

If you are looking for some new additions to your portfolio in May, then the ASX 200 stocks listed below could be worth a closer look. That's because they have been named on Bell Potter's Australian Equities Panel for the month. The bro...

I believe investing in ASX shares is one of the best decisions that Aussies can make. However, I wouldn't invest in every ASX share. There are certain sectors and types of businesses that I'd avoid investing in for my own portfolio. It's...

The S&P/ASX 200 Index (ASX: XJO) enjoyed a strong finish this Friday in what has been a strong week for the share market. By the time the closing bell rang, the ASX 200 had jumped up a healthy 1.13...

Highlights: Dateline Resources’ share price surged after political attention on rare earth minerals. Peninsula Energy experiences leadership changes amid halted trading and a downgrade. Biotech companies Telix and Dimerix fa...

This week the Wealth Within team talk about Lynas Rare Earths (LYC) which has reported 22% higher sales revenue from the same time last year and strong production volumes. Having said that, the revenue is down from the December quarter....

Highlights: The ASX advanced for a third straight session, led by strength in technology, healthcare, and financial sectors Materials sector declined amid soft performance from mining heavyweights despite broader market strength...

ASX 200 healthcare shares finished in the green on Tuesday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) lifting 0.61%. Healthcare is seen as a defensive sector. In today's turbulent market, perhaps you might be looking for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin ASX200 futures are pointing to another positive open, post a flattish performance on...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin New approval provides French hospitals and clinics with access to a proven PSMA...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a positive fashion. The benchmark index rose 0.35% to 7,997.1 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected...

In this week’s video insight, I discuss the growth of Telix Pharmaceuticals (ASX:TLX). When the Montgomery Fund, The Montgomery [Private] Fund, and the Australian Eagle Trust Long Short Funds first invested in TLX, the share price was aroun...

Highlights ASX extends rally with strong gains across sectors. Tech stocks mirror Wall Street’s upbeat performance. Banks bolster the market while miners lag. The Australian share market notched its third consecutive session of ga...

Highlights: ASX opens higher, buoyed by Wall Street’s rally and hopes of China stimulus. Tech stocks lead the charge on ASX, with NextDC posting notable gains. Telix experiences a setback as FDA decision impacts stock perfor...

Telix (ASX:TLX) has copped a sharp jab on Monday as the FDA says its drug TLX101-CDx, AKA Floretyrosine, can’t be accepted for imaging the rare brain cancer glioma. In short, the US regulator is asking for more data from Telix with rega...

The ASX200 has been up 0.8% at 8,032 points in early afternoon trades. Telix Pharmaceuticals (ASX:TLX) has been among the most watched on HotCopper forums today after the US Food and Drug Administration ruled the company’s New Drug Appli...

The FDA has told Telix to do more work on its imaging agent for rare brain cancers But the agency tells Dimerix it can use a surrogate endpoint for its kidney disease drug candidate Emvision opens a second US site to test its stroke detect...

Highlights ASX lifted by strength in banks and tech sectors. Telix Pharmaceuticals drops on regulatory setback. Miners lag as iron ore prices slip. The Australian sharemarket advanced firmly into positive territory, buoyed by gain...

Highlights  ASX rises 1% amid China stimulus hopes  Technology sector leads local market gains  Telix tumbles after US regulatory setback  Australia's sharemarket opened the week on a strong note, lifted by optimism around potenti...

The S&P/ASX 200 Index (ASX: XJO) is starting the week on a positive note. At the time of writing, the benchmark index is up 0.7% to 8,023.9 points. Four ASX shares that have failed to follow the market higher today are listed below. He...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are tumbling on Monday morning. At the time of writing, the radiopharmaceuticals company's shares are down 8% to $26.35. Why are Telix shares sinking? Investors have been selling the company's sha...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is under the spotlight after announcing a negative update from the US FDA. Telix Pharmaceuticals describes itself as a biopharmaceutical company that’s focused on the development and comm...